Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present InMed Pharmaceuticals, Inc. (OTC: IMLFF).

Full DD Report for IMLFF

You must become a subscriber to view this report.


Recent News from (OTC: IMLFF)

Venture Breakfast Bits, by 24/7 Market News
Venture Market News for September 7, 2018 Namaste Signs Cannabis Purchase Agreement With Tilray® VANCOUVER, Sept. 7, 2018 /CNW/ - Namaste Technologies Inc. ("Namaste" or the "Company") (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) is pleased to announce that the Company has signed ...
Source: 24/7 Market News
Date: September, 07 2018 09:34
InMed Pharmaceuticals to Report Fourth Quarter, and Full Year Fiscal 2018 Financial Results and Business Update on September 13, 2018
InMed Pharmaceuticals to Report Fourth Quarter, and Full Year Fiscal 2018 Financial Results and Business Update on September 13, 2018 Canada NewsWire VANCOUVER, Sept. 7, 2018 VANCOUVER , Sept. 7, 2018 /CNW/ -  InMed Pharmaceuticals Inc. ("InMed" or the "Company") (T...
Source: Canada Newswire
Date: September, 07 2018 07:25
InMed Pharmaceuticals to Present at the H.C. Wainwright 20th Annual Global Investment Conference
TSX:IN OTCQX:IMLFF VANCOUVER , Aug. 31, 2018 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary bioinformatics and biosynthesis platform technolo...
Source: PR Newswire
Date: August, 31 2018 07:25
5 of Today's Biggest Marijuana Stock Losers - Monday, August 13th
Out of over 200+ marijuana stocks, here are just 5 of the biggest marijuana stock losers in trading on Monday, August 13th including Affinor Growers Inc. (CSE:AFI) (OTC:RSSFF) and more... Affinor Growers Inc. (OTC:RSSFF) (CSE:AFI) Shares of Affinor Growers Inc. dropped 8.54% today on hi...
Source: Daily Marijuana Observer
Date: August, 13 2018 18:48
InMed to Present at the Canaccord Genuity 38th Annual Growth Conference
InMed to Present at the Canaccord Genuity 38th Annual Growth Conference Canada NewsWire VANCOUVER, Aug. 1, 2018 VANCOUVER , Aug. 1, 2018 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmac...
Source: Canada Newswire
Date: August, 01 2018 07:25
OTC Markets Group Announces Quarterly Index Performance and Rebalancing
NEW YORK , July 25, 2018 /PRNewswire/ --  OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the second quarter 2018 performance and quarterly rebalancing of the OTCQX® and OTCQB® indexes, including th...
Source: PR Newswire
Date: July, 25 2018 07:00
5 of Today's Biggest Marijuana Stock Gainers - Thursday, July 5th
Out of over 200+ marijuana stocks , here are 5 of the biggest marijuana stock winners in trading on Thursday, July 5th including CV Sciences, Inc. (OTC:CVSI) and more... Cannabics Pharmaceuticals Inc. (OTC:CNBX) Shares of Cannabics Pharmaceuticals Inc. rose 5.00% on higher than average tr...
Source: Daily Marijuana Observer
Date: July, 05 2018 17:10
Weekly Cannabis Report: Molson Coors, Shopify, Tilray, Legal Sales
Welcome to our Weekly Cannabis Report, a reliable source for cannabis investors to receive the latest developments and analysis. Trading Summary Last week, the widely-tracked Horizons Marijuana Life Sciences Index ETF ( HMLSF ) traded up 6.9% and ended the week at $19.68. Horizons Emergi...
Source: SeekingAlpha
Date: June, 26 2018 19:11
5 of Today's Biggest Marijuana Stock Losers - Tuesday, June 26th
Out of over 200+ marijuana stocks, here are just 5 of the biggest marijuana stock losers in trading on Tuesday, June 26th including AXIM Biotechnologies, Inc. (OTC:AXIM) and more... AXIM Biotechnologies, Inc. (OTC:AXIM) Shares of AXIM Biotechnologies, Inc. dropped 13.76% today on lower ...
Source: Daily Marijuana Observer
Date: June, 26 2018 16:58
InMed Pharmaceuticals Announces the Closing of C$14.95 Million Bought Deal Financing including Full Exercise of Underwriter's Over-Allotment Option
InMed Pharmaceuticals Announces the Closing of C$14.95 Million Bought Deal Financing including Full Exercise of Underwriter's Over-Allotment Option Canada NewsWire VANCOUVER, June 21, 2018 /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN T...
Source: Canada Newswire
Date: June, 21 2018 11:13

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-110.3250.33320.348740.313512,579
2018-12-100.3750.3194550.390.3185431,676
2018-12-070.3160.359410.37550.3079753,807
2018-12-060.3550.31540.3550.291,048,913
2018-12-050.400.36350.400.351483,822

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-10114,317423,67626.9822Cover
2018-12-07466,952753,80761.9458Short
2018-12-06571,0881,048,91354.4457Short
2018-12-04160,497483,82233.1727Cover
2018-12-03146,487338,71043.2485Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on IMLFF.


About InMed Pharmaceuticals, Inc. (OTC: IMLFF)

Logo for InMed Pharmaceuticals, Inc. (OTC: IMLFF)

lt p gt InMed Pharmaceuticals Inc. is a pre clinical stage biopharmaceutical company specializing in the research, development and commercialization of cannabinoid based therapies to treat human diseases with high unmet medical needs. The Company has three core assets: a proprietary Bioinformatics assessment tool to match individual or combination of cannabinoids against disease targets a proprietary Biosynthesis cannabinoid manufacturing system to economically produce all cannabinoids at pharmaceutical grade gt . purity and drug development program enabled by the two aforementioned tools. Leaders in the pipeline include a treatment for the symptoms and, potentially, the underlying disease in Epidermolysis Bullosa, a rare, devastating genetic skin disorder and, a once a day eyedrops formulation of cannabinoids to treat Glaucoma, one of the leading causes of blindness in the developed world.

 

Contact Information

 

 

Current Management

  • Eric A. Adams / CEO
  • Jeff Charpentier / CFO
  • Sazzad Hossain / Chief Scientific Officer
  • Martin Bott / Independent Director, Audit Committee Member
  • Adam Cutler / Independent Director, Audit Committee Member
  • William Garner / Independent Director, Compensation Committee Member
  • Andrew Hull / Independent Director, Compensation Committee Member

Current Share Structure

  • Market Cap: $190,238,229 - 03/09/2018
  • Issue and Outstanding: 152,190,583 - 02/13/2018

 


Recent Filings from (OTC: IMLFF)

OTCQB Certification - OTCQB Certification
Filing Type: OTCQB Certification - OTCQB CertificationFiling Source: OTC Markets
Filing Date: March, 01 2018
Supplemental Information - Certification of Interim Filings - CEO
Filing Type: Supplemental Information - Certification of Interim Filings - CEOFiling Source: OTC Markets
Filing Date: February, 22 2018
Supplemental Information - Certificacion of interim filings - CFO
Filing Type: Supplemental Information - Certificacion of interim filings - CFOFiling Source: OTC Markets
Filing Date: February, 22 2018
Management Discussion and Analysis - Managements Discussion and Analysis
Filing Type: Management Discussion and Analysis - Managements Discussion and AnalysisFiling Source: OTC Markets
Filing Date: February, 22 2018
Quarterly Report - Financial Statements December 31 2017
Filing Type: Quarterly Report - Financial Statements December 31 2017Filing Source: OTC Markets
Filing Date: February, 22 2018
OTCQB Certification - OTCQB Certification
Filing Type: OTCQB Certification - OTCQB CertificationFiling Source: OTC Markets
Filing Date: February, 13 2018
Supplemental Information - Report of exempt distribution excluding Schedule 1 of 45-106F1
Filing Type: Supplemental Information - Report of exempt distribution excluding Schedule 1 of 45-106F1Filing Source: OTC Markets
Filing Date: January, 10 2018
Supplemental Information - Material Change Report
Filing Type: Supplemental Information - Material Change ReportFiling Source: OTC Markets
Filing Date: January, 08 2018
Supplemental Information - Certification of Interim Filings - CFO
Filing Type: Supplemental Information - Certification of Interim Filings - CFOFiling Source: OTC Markets
Filing Date: November, 21 2017
Supplemental Information - Certification of Interim Filings - CEO
Filing Type: Supplemental Information - Certification of Interim Filings - CEOFiling Source: OTC Markets
Filing Date: November, 21 2017

 

 


Daily Technical Chart for (OTC: IMLFF)

Daily Technical Chart for (OTC: IMLFF)


Stay tuned for daily updates and more on (OTC: IMLFF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: IMLFF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in IMLFF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of IMLFF and does not buy, sell, or trade any shares of IMLFF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/